HCA vs PPCB · P/E 17, rev $75.60B vs P/E 0.0, $3.9M cap
HCA Holdings Inc (HCA) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
PPCB does not have a complete income-statement cache yet.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the HCA and PPCB stock pages for the full models.
Not investment advice.